UP!
|
Type
|
Public |
|---|---|
| Traded as | NASDAQ: CBPO |
| Industry | Biotechnology |
| Headquarters | Beijing, China |
| Website | www |
China Biologic Products, Inc., through its indirect majority-owned subsidiary Shandong Taibang, is the only blood plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province in China with a population of 93 million. The company is engaged in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Plasma-based human albumin is used mainly to increase blood volume while Immunoglobulin is used for disease prevention and treatment.
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q1 2021 | 2021-05-18 | Future report Set alerts | |
| Q4 2020 | 2021-03-29 | 0.91 | 0.91 |
| Q3 2020 | 2020-11-11 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-17 | 1.11 | 0.91 |
| Q1 2020 | 2020-05-20 | 1.56 | 1.36 |
| Q4 2019 | 2020-03-12 | 0.53 | 0.32 |
| Q3 2019 | 2019-11-13 | 1.40 | 1.21 |
| Q2 2019 | 2019-08-05 | 1.24 | 1.06 |
| Q1 2019 | 2019-05-10 | 1.11 | 0.94 |
| Q4 2018 | 2019-03-06 | 0.76 | 0.87 |
| 2016-07-05 | Upgrade | Credit Suisse Group AG | Neutral to Outperform | |
| 2016-06-04 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-03-01 | Downgrade | Credit Suisse | Outperform to Neutral | $129.00 |
| 2016-03-01 | Downgrade | Credit Suisse Group AG | Outperform to Neutral | $129.00 |
| 2016-02-29 | Lower Price Target | Jefferies Group | Buy | $138.00 to $136.00 |
| 2016-01-07 | Boost Price Target | Deutsche Bank | Buy | $149.00 to $162.00 |
| 2016-01-07 | Boost Price Target | Deutsche Bank AG | Buy | $149.00 to $162.00 |
| 2015-10-08 | Initiated Coverage | Credit Suisse | Outperform | |
| 2015-09-04 | Reiterated Rating | Jefferies Group | Buy | $146.00 |
| 2015-07-13 | Initiated Coverage | Deutsche Bank | Buy | $149.00 |
| 2015-07-09 | Initiated Coverage | Bank of America | Buy | $135.00 |
| 2015-07-09 | Initiated Coverage | Bank of America Corp. | Buy | $135.00 |
| 2015-06-12 | Reiterated Rating | Jefferies Group | Buy | $115.00 to $122.00 |
| 2014-11-06 | Reiterated Rating | Jefferies Group | Buy | $57.00 to $76.00 |
| 2014-09-03 | Reiterated Rating | Aegis | Buy | $55.00 to $59.00 |
| 2014-07-24 | Reiterated Rating | Jefferies Group | Buy | $52.00 to $57.00 |
| 2014-07-08 | Reiterated | Aegis Capital | Buy | $50 to $55 |
| 2014-07-08 | Boost Price Target | Aegis | Buy | $50.00 to $55.00 |
| 2014-05-22 | Initiated Coverage | Jefferies Group | Buy | $52.00 |
| 2014-03-17 | Upgrade | Aegis | Buy | |
| 2014-03-14 | Initiated | Oppenheimer | Outperform | $46 |
| 2014-03-13 | Initiated Coverage | Oppenheimer | Outperform | $46.00 |
| 2013-11-06 | Downgrade | Aegis Capital | Buy to Hold | |
| 2013-11-06 | Downgrade | |||
| 2013-11-06 | Downgrade | Aegis | Buy to Hold | |
| 2013-03-14 | Reiterated | Aegis Capital | Buy | $22 to $28 |
| 2010-05-13 | Reiterated | Brean Murray | Buy | $19 to $20 |
| 2010-03-26 | Reiterated | Brean Murray | Buy | $15 to $19 |
| 2016-07-05 | Upgrade | Credit Suisse Group AG | Neutral to Outperform | |
| 2016-06-04 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-03-01 | Downgrade | Credit Suisse | Outperform to Neutral | $129.00 |
| 2016-03-01 | Downgrade | Credit Suisse Group AG | Outperform to Neutral | $129.00 |
| 2016-02-29 | Lower Price Target | Jefferies Group | Buy | $138.00 to $136.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CBPO 20 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| WARBURG PINCUS & CO. | 8.34M |
| BlackRock Fund Advisors | 0.38M |
| BlackRock Institutional Trust Company, N.A. | 0.31M |
| OXFORD ASSET MANAGEMENT | 0.26M |
| BlackRock Group LTD | 0.21M |
| Apex Capital Management | 0.13M |
| Standard Life Investments LTD | 0.13M |
| MANAGED ACCOUNT ADVISORS LLC | 44521 |
| RUSSELL FRANK CO/ | 33144 |
| OMNI PARTNERS LLP | 32065 |
| Coupland Cardiff Asset Management LLP | 12000 |
| AHL Partners LLP | 10829 |
| FolioMetrix LLC | 6477 |
| PIONEER INVESTMENT MANAGEMENT INC | 6100 |
| Hutchin Hill Capital, LP | 6000 |
UM